Entrada Therapeutics, Inc. (TRDA)
12.89
-0.07
(-0.54%)
USD |
NASDAQ |
Apr 28, 16:00
12.87
-0.02
(-0.16%)
After-Hours: 20:00
Entrada Therapeutics Research and Development Expense (TTM) : 136.44M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 102.38M |
| Biogen, Inc. | 1.498B |
| EyePoint, Inc. | 221.04M |
| Vertex Pharmaceuticals, Inc. | 3.929B |
| Arcutis Biotherapeutics, Inc. | 77.05M |